Bioceramic materials manufacturer Himed and 3D printing specialist Lithoz have opened a joint Bioceramic Center of Excellence (BCoE) at Himed’s headquarters in New York. The BCoE brings together decades of expertise from both companies to advance the development of 3D-printed bioceramic-based implants.
Due to the trend towards longer life expectancy, the demand for bioceramic implants is growing – the market is expected to grow to 10.2 billion US dollars by 2028. Lithoz’ ceramic 3D printing technology LCM opens up new opportunities for Himed, which is now expanding its offering to include additive manufacturing of prototypes and implants.
The center offers a comprehensive service from design support and 3D printing to analysis and characterization of materials. A Lithoz CeraFab S65 Medical printer is available for the production of bioceramic components. The expertise of Himed’s engineers and scientists accompanies the entire process.
“Lithoz’ technology is unique and solves many challenges. Their printers allow you to go from idea to production – this opens up completely new avenues in implant design,” says Himed CEO Dana Barnard, explaining the benefits.
“This bioceramics center opens a new chapter for 3D printed medical applications in North America. We are excited to enable Himed’s bioceramic innovations with our technology,” says Lithoz CEO Johannes Homa.
Subscribe to our Newsletter
3DPresso is a weekly newsletter that links to the most exciting global stories from the 3D printing and additive manufacturing industry.
